✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
Updated: 2026-05-29 · v2.0 · Prof. G. Pkhakadze, MD, MPH, PhDCiteEditorial
📰Read the full Evening Primrose Oil evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.
2
Conditional
Evening Primrose Oil
Oenothera biennis (GLA)
Conditionally SafeModerateFatty Acids
RDA
Typical 1–4 g oil
Target
N/A
Upper limit
No UL
Products
160
Dosage by population group — reference
🔗 Best with: Omega-3 (EPA), Vitamin E, Borage Oil / GLA✅ IFOS (International Fish Oil Standards), USP Verified, NSF Contents Certified
⚠ PMS: meta-analysis NEGATIVE [2]
⚠ Mastalgia: UK license WITHDRAWN for lack of efficacy [2]
⚠ Eczema: Cochrane INCONCLUSIVE [2]
⚠ One of the biggest gaps between marketing and evidence in supplements [2]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
ℹ️ No validated blood test. There is no established laboratory test to assess status or guide dosing for this ingredient. Clinical response and symptoms are the practical guide.
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
EPO is one of the most popular supplements with the LEAST supporting evidence. PMS: meta-analysis negative. Mastalgia: UK license withdrawn for lack of efficacy. Eczema: Cochrane inconclusive. The GLA→PGE1 biochemistry is real, but clinical translation has failed for most marketed uses. GLA may help diabetic neuropathy and RA [1] [2].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Generally safe early. Avoid third trimester (prostaglandin effects) [1].
👦 Pediatric: See guidance
Limited data. Used in some eczema trials in children [2].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose

How to take

🍽 Timing: TID with meals [1].
💊 With food: With food (fat enhances absorption) [1].
🚫 Avoid: Third trimester. Anticoagulants. Phenothiazines [1].
2 Which form?
FormBioavailabilityVeganCost
['Evening primrose oil capsules', 'common', '500–1,000 mg per capsule. 8–10% GLA [1].']StandardCheck label
['Borage oil', '', 'Higher GLA content (~24%) — alternative GLA source [1].']StandardCheck label
3 Common questions
Does EPO help PMS? ▼
Despite massive popularity for PMS, the meta-analysis found NO convincing benefit [2]. Women who feel it helps may be experiencing placebo response or incidental variation in PMS severity.
Does EPO help breast pain? ▼
Most trials are negative. The UK Medicine Control Agency withdrew its license for mastalgia due to lack of efficacy [2].
Is there anything EPO IS good for? ▼
GLA (from any source) has the best evidence for diabetic neuropathy and possibly RA joint stiffness [1]. But EPO specifically for PMS, mastalgia, and eczema is not well-supported.
4 Clinical evidence

Strong

GLA → DGLA → PGE1 pathway: established biochemistry [1]. HIGH

Moderate

Diabetic neuropathy: some older trials positive for GLA (from EPO). Cochrane review of eczema: insufficient evidence [2]. Rheumatoid arthritis: modest evidence for GLA reducing morning stiffness/joint pain [1]. MODERATE

Insufficient

PMS: meta-analysis found NO convincing benefit [2]. Mastalgia: most trials negative [2]. Eczema/atopic dermatitis: Cochrane inconclusive [2]. Menopause: insufficient [1]. Hot flashes [1]. Acne [1]. ALL major marketed indications lack strong evidence [2]. LOW
5 Safety, toxicity & adverse events

Absolute contraindications

✕ Seizure disorder — may lower seizure threshold, especially with phenothiazines

Relative

⚠ Anticoagulants/antiplatelets — bleeding risk
⚠ Discontinue before surgery
⚠ Pregnancy — conflicting data on labour effects

🚩 Red flags

● Patient spending money on EPO for PMS — evidence is negative [2]
● Anticoagulant patient [1]
6 Interactions

Drug interactions

Anticoagulants Moderate
Mechanism: GLA antiplatelet effects. [1]
Effect: Bleeding risk. [1]
Action: Monitor [1].

Supplement synergies

Omega-3 fish oil · 1–2 g EPA+DHA
GLA (omega-6) + EPA (omega-3) for balanced prostaglandin production [1].
7 Regulatory
United Kingdom: License for mastalgia was WITHDRAWN due to insufficient efficacy evidence [2].
United States: Dietary supplement [1].
8 US supplement products
160
on-market products containing Evening Primrose Oil (NIH DSLD)

Brands carrying Evening Primrose Oil (91)

Click a brand to see its Evening Primrose Oil products.
Or browse all 160 products in one list →
Evening Primrose Oil vs Omega-3Evening Primrose Oil vs Vitamin E
9 Cite this page
Vancouver: Pkhakadze G. Evening Primrose Oil — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/ingredients/evening-primrose-oil/
APA 7th: Pkhakadze, G. (2026). Evening Primrose Oil — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/evening-primrose-oil/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: April 2027
References: 2 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Evening Primrose Oil — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/evening-primrose-oil/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network